Zobrazeno 1 - 5
of 5
pro vyhledávání: '"maternally sequestered drug delivery"'
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundPreeclampsia is a hypertensive syndrome that complicates 3% to 5% of pregnancies in the United States. Preeclampsia originates from an improperly vascularized and ischemic placenta that releases factors that drive systemic pathophysiology.
Externí odkaz:
https://doaj.org/article/e156a79a396049f3ae33d9627d9fa59f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
George, Eric M.1 (AUTHOR), Liu, Huiling2 (AUTHOR), Robinson, Grant G.2 (AUTHOR), Bidwell, Gene L.2 (AUTHOR) gbidwell@umc.edu
Publikováno v:
Journal of Drug Targeting. Dec2014, Vol. 22 Issue 10, p935-947. 13p.
Publikováno v:
Pregnancy Hypertension; Oct2018:Supplement 1, Vol. 13, pS123-S123, 1p
Publikováno v:
Pregnancy Hypertension. 13:S123
Introduction Preeclampsia is a hypertensive syndrome of pregnancy with few pharmacological treatment options. The risk of for adverse fetal effects is a major limitation for drug development. Our lab has developed a protein-based drug carrier called
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ff5e7191dbfd28a7e4b69c4558f44b3
https://doi.org/10.1016/j.preghy.2018.08.363
https://doi.org/10.1016/j.preghy.2018.08.363